Literature DB >> 11282094

Urine 4-heptanone: a beta-oxidation product of 2-ethylhexanoic acid from plasticisers.

V Walker1, G A Mills.   

Abstract

4-Heptanone is a common volatile constituent of human urine and is of unknown origin. We hypothesised that it arises from in vivo beta-oxidation of 2-ethylhexanoic acid (EHA) from plasticisers, similar to formation of 3-heptanone from valproic acid. We investigated urine from individuals with normal and increased plasticiser exposure. Using GC/MS, solvent-extracted organic acids were analysed as trimethylsilyl (TMS) derivatives and heptanone with headspace solid-phase microextraction. We identified 3-oxo-2-ethylhexanoic acid, the beta-oxidation product of EHA, as an enol in all samples. This is the first report of its TMS mass spectrum. We also found 2-ethyl-1,6-hexanedioic acid and 5-hydroxyEHA, omega- and omega-1-oxidation products of EHA, respectively, and 2-ethylhexanoylglucuronide, but only in trace amounts in some plasticiser samples. These compounds have not been reported in human urine, nor has the TMS mass spectrum of 5-hydroxyEHA. The median concentrations of 3-oxoethylhexanoic acid and total 4-heptanone of seven plasticiser samples were around 30--175-fold higher than normal samples. 4-Heptanone was barely detectable and 3-oxoethylhexanoic acid was not increased in an eighth plasticiser sample, from a baby with deficiency of 2-methylbranched-chain acyl-CoA dehydrogenase. beta-Oxidation is a major catabolic pathway of EHA in man, and might be involved in the metabolism of other branched-chain drugs and environmental pollutants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282094     DOI: 10.1016/s0009-8981(01)00390-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.

Authors:  W Filipiak; V Ruzsanyi; P Mochalski; A Filipiak; A Bajtarevic; C Ager; H Denz; W Hilbe; H Jamnig; M Hackl; A Dzien; A Amann
Journal:  J Breath Res       Date:  2012-09       Impact factor: 3.262

Review 2.  The Role of Protein Adduction in Toxic Neuropathies of Exogenous and Endogenous Origin.

Authors:  Peter S Spencer; Xiao Chen
Journal:  Toxics       Date:  2021-04-29

3.  Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.

Authors:  C L Silva; M Passos; J S Câmara
Journal:  Br J Cancer       Date:  2011-11-15       Impact factor: 7.640

4.  Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.

Authors:  Paweł Mochalski; Julian King; Matthias Haas; Karl Unterkofler; Anton Amann; Gert Mayer
Journal:  BMC Nephrol       Date:  2014-03-08       Impact factor: 2.388

5.  Use of the Endophytic Fungus Daldinia cf. concentrica and Its Volatiles as Bio-Control Agents.

Authors:  Orna Liarzi; Einat Bar; Efraim Lewinsohn; David Ezra
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

6.  Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.

Authors:  Paweł Mochalski; Andreas Sponring; Julian King; Karl Unterkofler; Jakob Troppmair; Anton Amann
Journal:  Cancer Cell Int       Date:  2013-07-17       Impact factor: 5.722

Review 7.  Biotransformations utilizing β-oxidation cycle reactions in the synthesis of natural compounds and medicines.

Authors:  Alina Swizdor; Anna Panek; Natalia Milecka-Tronina; Teresa Kołek
Journal:  Int J Mol Sci       Date:  2012-12-05       Impact factor: 5.923

8.  Genetically-based olfactory signatures persist despite dietary variation.

Authors:  Jae Kwak; Alan Willse; Koichi Matsumura; Maryanne Curran Opiekun; Weiguang Yi; George Preti; Kunio Yamazaki; Gary K Beauchamp
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

9.  Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro.

Authors:  Paweł Mochalski; Markus Theurl; Andreas Sponring; Karl Unterkofler; Rudolf Kirchmair; Anton Amann
Journal:  Cell Biochem Biophys       Date:  2015-01       Impact factor: 2.194

10.  Quantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitro.

Authors:  Paweł Mochalski; Ramona Al-Zoairy; Andreas Niederwanger; Karl Unterkofler; Anton Amann
Journal:  J Breath Res       Date:  2014-10-13       Impact factor: 3.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.